Gv 2017 Gp, L.L.C.

Insider Reports History

Entity
Company
Location
1600 Amphitheatre Parkway, Mountain View, CA
Signature
/s/ Inga Goldbard, General Counsel of GV 2017 GP, L.L.C.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gv 2017 Gp, L.L.C.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gitlab Inc. 10%+ Owner Class B Common Stock 8.89M $561M $63.12 Oct 18, 2021 By GV 2017, L.P.
Verve Therapeutics, Inc. Member of 10% Group Common Stock 6.11M $61.1M $10.00 Nov 4, 2022 By GV 2017 L.P.
Verve Therapeutics, Inc. Member of 10% Group Common Stock 4.26M $42.6M $10.00 Nov 4, 2022 By GV 2019 L.P.
Gitlab Inc. 10%+ Owner Series C Preferred Stock 0 Oct 18, 2021 By GV 2017, L.P.
Gitlab Inc. 10%+ Owner Series D Preferred Stock 0 Oct 18, 2021 By GV 2017, L.P.
Verve Therapeutics, Inc. Member of 10% Group Common Stock 0 $10.00 Nov 4, 2022 By Alphabet Holdings LLC
Verve Therapeutics, Inc. Member of 10% Group Series A Preferred Stock 0 Jun 21, 2021 By GV 2017, L.P.

Insider Reports Filed by Gv 2017 Gp, L.L.C.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VERV Verve Therapeutics, Inc. Nov 4, 2022 7 -$3.03M 4 Nov 8, 2022 Member of 10% Group
VERV Verve Therapeutics, Inc. Nov 2, 2022 14 -$5.31M 4 Nov 4, 2022 Member of 10% Group
VERV Verve Therapeutics, Inc. Oct 31, 2022 16 -$6.5M 4 Nov 2, 2022 Member of 10% Group
GTLB Gitlab Inc. Oct 18, 2021 3 $0 4 May 6, 2022 10%+ Owner
GTLB Gitlab Inc. Oct 13, 2021 0 $0 3 May 6, 2022 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 21, 2021 2 $0 4 Jun 22, 2021 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 10%+ Owner